Development Level

Tbio 11 | 11,651
Tclin 6 | 612
Tchem 4 | 1,388
Tdark 2 | 6,593

IMPC Phenotype

cataract 1 | 92
decreased blood urea nitrogen ... 1 | 51
decreased circulating triglyce... 1 | 79
decreased mean platelet volume 1 | 25
hyperactivity 1 | 148
preweaning lethality, incomple... 1 | 499

Disease

Carcinoma 18 | 11,493
psoriasis 11 | 6,694
medulloblastoma, large-cell 9 | 6,241
Cancer 8 | 2,499
interstitial cystitis 8 | 2,312
Prostatic Neoplasms 7 | 495
intraductal papillary-mucinous neoplasm (IPMN) 7 | 3,291
osteosarcoma 7 | 7,950
ovarian cancer 7 | 8,520
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 6 | 2,989
lung adenocarcinoma 6 | 2,716
lung carcinoma 6 | 2,843
Breast Neoplasms 5 | 445
Breast cancer 5 | 3,578
Mammary Neoplasms 5 | 425
atypical teratoid / rhabdoid tumor 5 | 5,112
ductal carcinoma in situ 5 | 1,745
ependymoma 5 | 4,679
non-small cell lung cancer 5 | 2,890
oligodendroglioma 5 | 2,850
pancreatic ductal adenocarcinoma liver metastasis 5 | 1,962
Depressive Symptoms 4 | 28
Human immunodeficiency virus infection 4 | 6
Hypertension 4 | 396
Schizophrenia 4 | 1,160
adult high grade glioma 4 | 3,801
cutaneous lupus erythematosus 4 | 1,057
diabetes mellitus 4 | 1,728
glioblastoma 4 | 5,792
group 3 medulloblastoma 4 | 4,104
lung cancer 4 | 4,740
pancreatic cancer 4 | 2,398
pituitary cancer 4 | 1,972
Astrocytoma, Pilocytic 3 | 3,081
Drug-Related Side Effects and Adverse Reactions 3 | 62
Endometriosis 3 | 540
Hepatomegaly 3 | 285
Liver disease 3 | 237
Malaria 3 | 160
Precursor Cell Lymphoblastic Leukemia Lymphoma 3 | 43
Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 | 49
Schizophrenia and related disorders 3 | 8
adrenocortical adenoma 3 | 131
adrenocortical carcinoma 3 | 1,428
astrocytic glioma 3 | 2,597
primitive neuroectodermal tumor 3 | 3,035
substance-related disorder 3 | 162
tuberculosis 3 | 2,010
ulcerative colitis 3 | 1,819
Adverse reaction to drug 2 | 61
Alzheimer's disease 2 | 658
Autoimmune hepatitis 2 | 11
Autosomal recessive predisposition 2 | 1,442
Bradycardia 2 | 36
Carcinoma, Squamous Cell 2 | 110
Cardiomegaly 2 | 116
Chemical and Drug Induced Liver Injury 2 | 195
Cholestasis 2 | 155
Chronic Obstructive Airway Disease 2 | 37
Colorectal Neoplasms 2 | 243
Contact Dermatitis 2 | 81
Dermatitis, Contact 2 | 71
Diabetes Mellitus, Non-Insulin-Dependent 2 | 145
Fatty Liver 2 | 70
Hepatitis C 2 | 94
Intermittent claudication 2 | 20
Kidney Diseases 2 | 114
Lung Injury 2 | 20
Lung Neoplasms 2 | 232
Male infertility 2 | 206
Melanoma 2 | 711
Obesity 2 | 678
Occupational Diseases 2 | 12
Pain agnosia 2 | 104
Prostate cancer 2 | 175
Pulmonary Disease, Chronic Obstructive 2 | 31
Squamous cell carcinoma 2 | 129
active Crohn's disease 2 | 922
astrocytoma 2 | 1,146
breast carcinoma 2 | 1,638
chronic rhinosinusitis 2 | 512
esophageal adenocarcinoma 2 | 737
fascioscapulohumeral muscular dystrophy 2 | 100
head and neck cancer and chronic obstructive pulmonary disease 2 | 239
invasive ductal carcinoma 2 | 2,951
malignant mesothelioma 2 | 3,232
periodontitis 2 | 293
Amelogenesis imperfecta 1 | 29
Amelogenesis imperfecta type 1B 1 | 4
Amenorrhea 1 | 58
Amyotrophic lateral sclerosis type 5 1 | 13
Anovulation 1 | 21
Carcinoma of female breast 1 | 20
Chronic schizophrenia 1 | 16
Muscle Rigidity 1 | 49
Ovarian dysfunction 1 | 18
Ovarian hyperstimulation syndrome 1 | 19
Premature ovarian failure 1 | 65
Primary physiologic amenorrhea 1 | 55

Tissue

Digestive Tract 21 | 17,369
Endocrine System 21 | 18,159
Female tissues 21 | 17,400
Liver and Pancreas 20 | 16,750
Respiratory system 19 | 16,393
Skin and soft tissues 19 | 17,230
Blood and immune system 18 | 16,909
Male tissues 18 | 17,142
Urinary Tract 18 | 16,678
Nervous System 15 | 16,725
Cardiovascular System 10 | 15,192

Target Family

Non-IDG 17 | 12,091
Enzyme 6 | 4,145

GO Function

aromatase activity 23 | 23
metal ion binding 2,256 | 2,256
DNA binding 1,481 | 1,481
ATP binding 1,477 | 1,477
RNA binding 1,383 | 1,383
identical protein binding 1,084 | 1,084
zinc ion binding 828 | 828
transcription factor activity,... 816 | 816
protein homodimerization activ... 801 | 801
calcium ion binding 690 | 690
G-protein coupled receptor act... 658 | 658
protein heterodimerization act... 473 | 473
olfactory receptor activity 425 | 425
protein kinase binding 410 | 410
chromatin binding 378 | 378
receptor binding 374 | 374
sequence-specific DNA binding 374 | 374
GTP binding 372 | 372
protein serine-threonine kinas... 360 | 360
RNA polymerase II core promote... 346 | 346
enzyme binding 340 | 340
ubiquitin protein ligase bindi... 301 | 301
transcription factor binding 297 | 297
GTPase activity 286 | 286
GTPase activator activity 281 | 281
cadherin binding 277 | 277
transcriptional activator acti... 274 | 274
actin binding 272 | 272
ubiquitin-protein transferase ... 260 | 260
transcription coactivator acti... 249 | 249
serine-type endopeptidase acti... 246 | 246
protein domain specific bindin... 241 | 241
protein complex binding 231 | 231
structural molecule activity 229 | 229
microtubule binding 212 | 212
nucleic acid binding 210 | 210
signal transducer activity 208 | 208
transcription regulatory regio... 205 | 205
RNA polymerase II regulatory r... 204 | 204
receptor activity 202 | 202
transmembrane signaling recept... 202 | 202
ubiquitin protein ligase activ... 202 | 202
transcription corepressor acti... 200 | 200
magnesium ion binding 197 | 197
calmodulin binding 194 | 194
protein C-terminus binding 191 | 191
protein kinase activity 182 | 182
carbohydrate binding 178 | 178
RNA polymerase II transcriptio... 174 | 174
cytokine activity 171 | 171
antigen binding 169 | 169
growth factor activity 162 | 162
heparin binding 161 | 161
protein dimerization activity 161 | 161
structural constituent of ribo... 161 | 161
actin filament binding 151 | 151
iron ion binding 139 | 139
transcriptional activator acti... 139 | 139
Rab GTPase binding 138 | 138
transcriptional repressor acti... 135 | 135
transporter activity 134 | 134
heme binding 129 | 129
ATPase activity 128 | 128
lipid binding 127 | 127
SH3 domain binding 125 | 125
protein tyrosine kinase activi... 122 | 122
ion channel binding 118 | 118
mRNA binding 118 | 118
Ras guanyl-nucleotide exchange... 116 | 116
metalloendopeptidase activity 115 | 115
unfolded protein binding 113 | 113
integrin binding 112 | 112
histone binding 111 | 111
protease binding 108 | 108
histone deacetylase binding 107 | 107
structural constituent of cyto... 107 | 107
guanyl-nucleotide exchange fac... 106 | 106
protein N-terminus binding 106 | 106
peptide antigen binding 103 | 103
hormone activity 96 | 96
serine-type endopeptidase inhi... 96 | 96
odorant binding 94 | 94
kinase binding 92 | 92
single-stranded DNA binding 92 | 92
chaperone binding 91 | 91
oxidoreductase activity 91 | 91
protein tyrosine phosphatase a... 91 | 91
PDZ domain binding 87 | 87
thiol-dependent ubiquitinyl hy... 86 | 86
kinase activity 84 | 84
transcriptional repressor acti... 84 | 84
beta-catenin binding 83 | 83
hydrolase activity 80 | 80
peptidase activity 80 | 80
protein binding, bridging 80 | 80
ATPase binding 79 | 79
double-stranded DNA binding 79 | 79
phospholipid binding 78 | 78
phosphatidylinositol binding 77 | 77
thiol-dependent ubiquitin-spec... 76 | 76
drug binding 75 | 75

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cytochrome P450 1A1 CYP1A1 Tchem Non-IDG -3.54987 3641.5 384
Cytochrome P450 2S1 CYP2S1 Tbio Non-IDG -1.30209 23.8 153
Cytochrome P450 4F12 CYP4F12 Tdark Non-IDG -0.88794 8.48 0
Cytochrome P450 4B1 CYP4B1 Tbio Non-IDG -1.80695 66.9 104
Cytochrome P450 2J2 CYP2J2 Tchem Non-IDG -2.12012 148.8 194
Cytochrome P450 3A7 CYP3A7 Tclin Enzyme -1.97551 88.1 164
Aromatase CYP19A1 Tclin Enzyme -3.38322 2409.0 449
Cytochrome P450 2C18 CYP2C18 Tbio Non-IDG -2.22456 162.7 57
Putative cytochrome P450 2D7 CYP2D7 Tbio Non-IDG 0.00000 0
Cytochrome P450 2F1 CYP2F1 Tbio Non-IDG -1.53384 31.3 68